CVM Archived Articles
CEL-SCI (NYSE:CVM): A Pioneering Immunotherapy Company Targeting the Unmet Need in Head and Neck Cancer
Published on March 14, 2025
CEL-SCI Corporation (NYSE:CVM): A Promising Immunotherapy Player Combating Head and Neck Cancer
Published on November 27, 2024
CEL-SCI Corporation (CVM): Pioneering Immunotherapy for Head and Neck Cancer with Promising Phase 3 Results
Published on September 24, 2024